Trial
NCT04133480
Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Lennox-Gastaut Syndrome
Intervention
GWP42003-P
Why stopped
The decision to withdraw the study was based on pandemic-related concerns of conducting a Phase IV study requiring multiple clinic visits when medication is commercially available. The study was withdrawn before any participants were recruited.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-01